Characterizing Deep Quality-of-Life Response in the TRuE-V1/TRuE-V2 Studies of Ruxolitinib Cream in Nonsegmental Vitiligo. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 May 2];10(2):s752. Available from: https://skin.dermsquared.com/skin/article/view/4072